Study Stopped
Lack of funding
IL-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction
Interleukin-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction.
1 other identifier
interventional
1
1 country
1
Brief Summary
Remote ischemic preconditioning has proven beneficial in patients undergoing percutaneous coronary intervention and coronary artery bypass surgery. Animal studies suggest remote ischemic preconditioning increases levels of interleukin 10. The investigators aim to determine whether remote ischemic preconditioning results in an increase in IL-10 levels in patients following acute myocardial infarction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2012
CompletedFirst Posted
Study publicly available on registry
February 14, 2012
CompletedStudy Start
First participant enrolled
March 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedMarch 25, 2016
March 1, 2013
11 months
February 9, 2012
March 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Interleukin 10 levels
24 hours following RIPC
Study Arms (2)
Remote ischemic preconditioning
EXPERIMENTALRemote ischemic preconditioning performed with Blood pressure cuff insufflation
Standard of care
NO INTERVENTIONStandard of care
Interventions
Blood pressure cuff will be inflated to a pressure of 200mmHg for 5 minutes. This will be repeated x 3, separated by 5 minutes.
Eligibility Criteria
You may qualify if:
- \- Acute myocardial infarction
You may not qualify if:
- \- Cardiogenic shock Active ischemia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven P Schulman, MD
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
February 9, 2012
First Posted
February 14, 2012
Study Start
March 1, 2013
Primary Completion
February 1, 2014
Study Completion
May 1, 2014
Last Updated
March 25, 2016
Record last verified: 2013-03